Natera, Inc. (NTRA) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Natera, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.092 Hello, everyone. Thank you for joining us and welcome to Natera's second quarter 00:00:05.092 -- 00:00:10.093 2026 earnings conference call. After today's prepared remarks, 00:00:10.093 -- 00:00:13.274 we will host a question and answer session. 00:00:13.274 -- 00:00:18.655 If you would like to ask a question, please press star one to raise your hand. 00:00:18.655 -- 00:00:24.076 To withdraw your question, press star one again. 00:00:24.076 -- 00:00:28.717 I will now hand the conference over to Michael Brophy, Chief Financial Officer. 00:00:28.717 -- 00:00:31.863 Michael. Please go ahead. 00:00:32.386 -- 00:00:36.429 Thanks, operator. Good afternoon. Thank you for joining our conference call to discuss 00:00:36.429 -- 00:00:39.652 the results of our second quarter of 2026. 00:00:39.652 -- 00:00:44.936 On the line, I'm joined by Steve Chapman, our CEO, Solomon Moshkevich, President, Clinical 00:00:44.936 -- 00:00:50.381 Diagnostics, and Alex Alessian, General Manager of Oncology and our Chief Medical Officer. 00:00:50.381 -- 00:00:53.763 Today's conference call is being broadcast live via webcast. 00:00:53.763 -- 00:00:58.466 We will be referring to a slide presentation that has been posted to investor.natera.com. 00:00:58.492 -- 00:01:03.914 A replay of the call will also be posted to our IR site as soon as it's available. 00:01:03.914 -- 00:01:07.796 Starting on slide two, during the course of this conference call, we will make forward-looking 00:01:07.796 -- 00:01:11.657 statements regarding future events and our anticipated future performance, such as our 00:01:11.657 -- 00:01:15.739 operational and financial outlook and projections, our assumptions for that outlook, 00:01:15.739 -- 00:01:20.281 market size, partnerships, clinic...